Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathology

Journal of Molecular Diagnostics

Volumn 17, Issue 1, 2015, Pages 10-18

  Hoogstraat, Marlous ^a,b   Hinrichs, John W J ^a   Besselink, Nicolle J M ^a,b   Radersma Van Loon, Joyce H ^a   De Voijs, Carmen M A ^a   Peeters, Ton ^a   Nijman, Isaac J ^a,b   De Weger, Roel A ^a   Voest, Emile E ^a,b   Willems, Stefan M ^a,b   Cuppen, Edwin ^a,b   Koudijs, Marco J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Netherlands Center for Personalized Cancer Treatment   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER PATHOLOGY; CANCER PATIENT; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC TRAIT; HUMAN; ONCOGENE K RAS; PATHOLOGY; PATIENT CARE; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WORKFLOW;

EID: 84963957158     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2014.09.004     Document Type: Article

References (30)

1. A.G. Hadd, J. Houghton, A. Choudhary, S. Sah, L. Chen, A.C. Marko, T. Sanford, K. Buddavarapu, J. Krosting, L. Garmire, D. Wylie, R. Shinde, S. Beaudenon, E.K. Alexander, E. Mambo, A.T. Adai, and G.J. Latham Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens J Mol Diagn 15 2013 234 247
2. W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, B. Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, D. Kupfer, R. Wilson, M. Kris, and H. Varmus EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 2004 13306 13311
3. R. Said, D.S. Hong, C.L. Warneke, J.J. Lee, J.J. Wheler, F. Janku, A. Naing, G.S. Falchook, S. Fu, S. Piha-Paul, A.M. Tsimberidou, and R. Kurzrock P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy Oncotarget 4 2013 705 714
4. E.H. Romond, E.A. Perez, J. Bryant, V.J. Suman, C.E. Geyer, N.E. Davidson, E. Tan-Chiu, S. Martino, S. Paik, P.A. Kaufman, S.M. Swain, T.M. Pisansky, L. Fehrenbacher, L.A. Kutteh, V.G. Vogel, D.W. Visscher, G. Yothers, R.B. Jenkins, A.M. Brown, S.R. Dakhil, E.P. Mamounas, W.L. Lingle, P.M. Klein, J.N. Ingle, and N. Wolmark Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
5. S.S. Lv, E.E. Teugels, J.J. Sadones, S.S. De Brakeleer, J.J. Duerinck, S.S. Four Du, A.A. Michotte, J.J. De Grève, and B.B. Neyns Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab Int J Oncol 41 2012 1029 1035
6. N. Kato, H. Itoh, A. Serizawa, Y. Hatanaka, S. Umemura, and R.Y. Osamura Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH) Pathol Int 60 2010 510 515
7. M.-M. Shao, F. Zhang, G. Meng, X.-X. Wang, H. Xu, X.-W. Yu, L.-Y. Chen, and G.M. Tse Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast Histopathology 59 2011 264 273
8. C.B. Moelans, R.A. de Weger, E. Van der Wall, and P.J. Van Diest Current technologies for HER2 testing in breast cancer Crit Rev Oncol Hematol 80 2011 380 392
9. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 2002 e57
10. J.E. Dancey, P.L. Bedard, N. Onetto, and T.J. Hudson The genetic basis for cancer treatment decisions Cell 148 2012 409 420
11. Y.-J. Bang, E. Van Cutsem, A. Feyereislova, H.C. Chung, L. Shen, A. Sawaki, F. Lordick, A. Ohtsu, Y. Omuro, T. Satoh, G. Aprile, E. Kulikov, J. Hill, M. Lehle, J. Rüschoff, Y.-K. Kang ToGA Trial Investigators Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 2010 687 697
12. C. Gravalos, and A. Jimeno HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target Ann Oncol 19 2008 1523 1529
13. R.A. Pazo Cid, and A. Antón Advanced HER2-positive gastric cancer: current and future targeted therapies Crit Rev Oncol Hematol 85 2013 350 362
14. M. Tanner, M. Hollmén, T.T. Junttila, A.I. Kapanen, S. Tommola, Y. Soini, H. Helin, J. Salo, H. Joensuu, E. Sihvo, K. Elenius, and J. Isola Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Ann Oncol 16 2005 273 278
15. S.-W. Han, H.-P. Kim, J.-Y. Shin, E.-G. Jeong, W.-C. Lee, K.-H. Lee, J.-K. Won, T.-Y. Kim, D.-Y. Oh, S.-A. Im, Y.-J. Bang, S.-Y. Jeong, K.J. Park, J.-G. Park, G.H. Kang, J.-S. Seo, J.-I. Kim, and T.-Y. Kim Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing PLoS One 8 2013 e64271
16. C.B. Moelans, R.A. de Weger, M.T.M. van Blokland, C. Ezendam, S. Elshof, M.G.J. Tilanus, and P.J. van Diest HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization Cell Oncol 31 2009 1 10
17. Iglewicz B, Hoaglin DC: How to Detect and Handle Outliers. ed 16. Milwaukee, WI, ASQC Quality Press, 1993
18. H.K. Gan, A.H. Kaye, and R.B. Luwor The EGFRvIII variant in glioblastoma multiforme J Clin Neurosci 16 2008 748 754
19. S.A. Forbes, N. Bindal, S. Bamford, C. Cole, C.Y. Kok, D. Beare, M. Jia, R. Shepherd, K. Leung, A. Menzies, J.W. Teague, P.J. Campbell, M.R. Stratton, and P.A. Futreal COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer Nucleic Acids Res 39 2010 D945 D950
20. E.J. Duncavage, H.J. Abel, P. Szankasi, T.W. Kelley, and J.D. Pfeifer Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia Mod Pathol 25 2012 795 804
21. K. Becker, C. Vollbrecht, U. Koitzsch, K. Koenig, J. Fassunke, S. Huss, P. Nuernberg, L.C. Heukamp, R. Buettner, M. Odenthal, J. Altmueller, and S. Merkelbach-Bruse Deep ion sequencing of amplicon adapter ligated libraries: a novel tool in molecular diagnostics of formalin fixed and paraffin embedded tissues J Clin Pathol 2013
22. C. Beadling, T.L. Neff, M.C. Heinrich, K. Rhodes, M. Thornton, J. Leamon, M. Andersen, and C.L. Corless Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping J Mol Diagn 15 2013 171 176
23. R.R. Singh, K.P. Patel, M.J. Routbort, N.G. Reddy, B.A. Barkoh, B. Handal, R. Kanagal-Shamanna, W.O. Greaves, L.J. Medeiros, K.D. Aldape, and R. Luthra Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes J Mol Diagn 15 2013 607 622
24. H.M. Wood, O. Belvedere, C. Conway, C. Daly, R. Chalkley, M. Bickerdike, C. McKinley, P. Egan, L. Ross, B. Hayward, J. Morgan, L. Davidson, K. MacLennan, T.K. Ong, K. Papagiannopoulos, I. Cook, D.J. Adams, G.R. Taylor, and P. Rabbitts Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens Nucleic Acids Res 38 2010 e151
25. J.L. Hayes, A. Tzika, H. Thygesen, S. Berri, H.M. Wood, S. Hewitt, M. Pendlebury, A. Coates, L. Willoughby, C.M. Watson, P. Rabbitts, P. Roberts, and G.R. Taylor Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation Genomics 102 2013 174 181
26. P. Medvedev, M. Stanciu, and M. Brudno Computational methods for discovering structural variation with next-generation sequencing Nat Methods 6 2009 S13 S20
27. J. Duan, J.-G. Zhang, H.-W. Deng, and Y.-P. Wang Comparative studies of copy number variation detection methods for next-generation sequencing technologies PLoS One 8 2013 e59128
28. L. Michaux, I. Wlodarska, M. Stul, J. Dierlamm, F. Mugneret, C. Herens, B. Beverloo, A. Verhest, C. Verellen-Dumoulin, G. Verhoef, D. Selleslag, V. Madoe, M. Lecomte, B. Deprijck, A. Ferrant, A. Delannoy, S. Marichal, C. Duhem, M. Dicato, and A. Hagemeijer MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23 Genes Chromosomes Cancer 29 2000 40 47
29. K.C. Rayeroux, and L.J. Campbell Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization Cancer Genet Cytogenet 193 2009 44 53
30. K.E. Barber, M. Martineau, L. Harewood, M. Stewart, E. Cameron, J.C. Strefford, S. Rutherford, T.D. Allen, Z.J. Broadfield, K.L. Cheung, R.L. Harris, G.R. Jalali, A.V. Moorman, H.M. Robinson, and C.J. Harrison Amplification of the ABL gene in T-cell acute lymphoblastic leukemia Leukemia 18 2004 1153 1156